-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EHYSIjycUguYTWVSuzk3MMCg9IwlFF5bBKQ8wJfGSU23K7bSQT47le2kQjvoOhWr OIg8C4rwWCtbNhdVgc7FnA== 0000099201-06-000023.txt : 20060411 0000099201-06-000023.hdr.sgml : 20060411 20060410201536 ACCESSION NUMBER: 0000099201-06-000023 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060411 DATE AS OF CHANGE: 20060410 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SEROLOGICALS CORP CENTRAL INDEX KEY: 0000767673 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 582152225 STATE OF INCORPORATION: DE FISCAL YEAR END: 1206 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-46047 FILM NUMBER: 06752033 BUSINESS ADDRESS: STREET 1: 5655 SPALDING DRIVE STREET 2: 5655 SPALDING DRIVE CITY: NORCROSS STATE: GA ZIP: 30092 BUSINESS PHONE: 4042965595 MAIL ADDRESS: STREET 1: 5655 SPALDING DRIVE STREET 2: 5655 SPALDING DRIVE CITY: NORCROSS STATE: GA ZIP: 30092 FORMER COMPANY: FORMER CONFORMED NAME: SEROLOGICALS HOLDINGS INC DATE OF NAME CHANGE: 19950418 FORMER COMPANY: FORMER CONFORMED NAME: SEROLOGICALS ACQUISITION INC DATE OF NAME CHANGE: 19950418 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TRANSAMERICA INVESTMENT MANAGEMENT LLC CENTRAL INDEX KEY: 0000099201 IRS NUMBER: 061564377 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1150 SOUTH OLIVE STREET STREET 2: SUITE 2700 CITY: LOS ANGELES STATE: CA ZIP: 90015 BUSINESS PHONE: 2137424141 MAIL ADDRESS: STREET 1: 1150 SOUTH OLIVE STREET STREET 2: SUITE 2700 CITY: LOS ANGELES STATE: CA ZIP: 90015 FORMER COMPANY: FORMER CONFORMED NAME: TRANSAMERICA INVESTMENT SERVICES INC DATE OF NAME CHANGE: 19920929 FORMER COMPANY: FORMER CONFORMED NAME: TRANSAMERICA INVESTMENT MANAGEMENT CO DATE OF NAME CHANGE: 19600201 SC 13G 1 serological0331.txt FORM 13G HOLDINGS REPORT UNITED STATES SECURITIES EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No. SEROLOGICALS CORP (Name of Issuer) Common Stock (Title of Class of Securities) 817523103 (CUSIP Number) March 31, 2006 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ X ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) CUSIP No. 817523103 1.Names of Reporting Persons. Transamerica Investment Management, LLC I.R.S. Identification Nos. of above persons (entities only). 06-1564377 2.Check the Appropriate Box if a Member of a Group (a) [ ] (b) [ X ] 3.SEC Use Only 4.Citizenship or Place of Organization Delaware, United States Number of Shares Beneficially Owned by Each Reporting Person With 5.Sole Voting Power 1,542,500 6.Shared Voting Power None 7.Sole Dispositive Power 1,711,076 8.Shared Dispositive Power None 9.Aggregate Amount Beneficially Owned by Each Reporting Person 1,711,076 10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares [ ] 11.Percent of Class Represented by Amount in Row (9) 5.01% 12.Type of Reporting Person: IA Item 1(a). Name of Issuer: SEROLOGICALS CORP Item 1(b). Address of Issuer's Principal Executive Offices: 5655 SPALDING DRIVE NORCROSS GA 30092 Item 2(a). Name of Person Filing Item 2(b). Address of Principal Business Office or, if None, Residence Item 2(c). Citizenship Transamerica Investment Management, LLC 1150 South Olive Street, Suite 2700 Los Angeles, CA 90015 Delaware Item 2(d). Title of Class of Securities: Common Stock Item 2(e). CUSIP Number: 817523103 Item 3. If This Statement is Filed Pursuant to 240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a: (a) - Broker or dealer registered under Section 15 of the Act. (b) - Bank as defined in Section 3(a)(6) of the Act. (c) - Insurance company as defined in Section 3(a)(19) of the Act. (d) - Investment company registered under Section 8 of the Investment Company Act of 1940. (e) X An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) - An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) - A parent holding company or control person in accordance with 240.13d- 1(b)(1)(ii)(G); (h) - A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) - A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940; (j) - Group, in accordance with 240.13d-1(b)(1)(ii)(J). Item 4. Ownership: a. Amount beneficially owned: 1,711,076 b. Percent of Class: 5.01% c. Number of shares as to which the person has: (i) Sole power to vote or to direct the vote: 1,542,500 (ii) Shared power to vote or to direct the vote: None (iii)Sole power to dispose or to direct the disposition of: 1,711,076 (iv) Shared power to dispose or to direct the disposition: None Item 5. Ownership of Five Percent or Less of a Class: Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person: [ X ] Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company of Control Person: Not applicable. Item 8. Identification and Classification of Members of the Group: Not applicable. Item 9. Notice of Dissolution of Group: Not applicable. Item 10.Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date April 10, 2006 By:/s/ Gary U. Rolle Name: Gary U. Rolle Title: Chief Investment Officer -----END PRIVACY-ENHANCED MESSAGE-----